Clinical Trial Update: Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta [Phase 1]

View source ↗

Summary

Phase 1 safety study of Fresolimumab in Osteogenesis Imperfecta has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• Fresolimumab (Fresolimumab)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Osteogenesis Imperfecta | Phase 1 | Status: COMPLETED | Results posted: 2024-10-08